Stock Research for ADAT


Featured Broker: Ally Invest

Get the due diligence for another stock.


ADAT Stock Chart & Research Data

The ADAT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ADAT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ADAT Due diligence Resources & Stock Charts

The ADAT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ADAT Detailed Price Forecast - CNN Money CNN View ADAT Detailed Summary - Google Finance
Yahoo View ADAT Detailed Summary - Yahoo! Finance Zacks View ADAT Stock Research & Analysis -

Stock Analysis

TradeIdeas View ADAT Trends & Analysis - Trade-Ideas Barrons View ADAT Major Holders - Barrons
NASDAQ View ADAT Call Transcripts - NASDAQ Seeking View ADAT Breaking News & Analysis - Seeking Alpha
Spotlight View ADAT Annual Report - OTC Report View ADAT OTC Short Report -
TradeKing View ADAT Fundamentals - TradeKing Charts View ADAT SEC Filings - Bar Chart
WSJ View Historical Prices for ADAT - The WSJ Morningstar View Performance/Total Return for ADAT - Morningstar
MarketWatch View the Analyst Estimates for ADAT - MarketWatch CNBC View the Earnings History for ADAT - CNBC
StockMarketWatch View the ADAT Earnings - StockMarketWatch MacroAxis View ADAT Buy or Sell Recommendations - MacroAxis
Bullish View the ADAT Bullish Patterns - American Bulls Short Pains View ADAT Short Pain Metrics -

Social Media Mentions

StockTwits View ADAT Stock Mentions - StockTwits PennyStocks View ADAT Stock Mentions - PennyStockTweets
Twitter View ADAT Stock Mentions - Twitter Invest Hub View ADAT Investment Forum News - Investor Hub
Yahoo View ADAT Stock Mentions - Yahoo! Message Board Seeking Alpha View ADAT Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ADAT - Insider Cow View Insider Transactions for ADAT - Insider Cow
CNBC View ADAT Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ADAT - OTC Markets
Yahoo View Insider Transactions for ADAT - Yahoo! Finance NASDAQ View Institutional Holdings for ADAT - NASDAQ

Stock Charts

FinViz View ADAT Stock Insight & Charts - StockCharts View ADAT Investment Charts -
BarChart View ADAT Stock Overview & Charts - BarChart Trading View View ADAT User Generated Charts - Trading View

Latest Financial News for ADAT

Authentidate Announces Name Change to AEON Global Health Corp to Reflect Broader Healthcare Focus and Innovative Solutions
Posted on Wednesday January 31, 2018

GAINESVILLE, Ga., Jan. 31, 2018 /PRNewswire/ -- Authentidate Holding Corp. (ADAT), announced today that it has completed its previously announced corporate name change to Aeon Global Health Corp.  The name change is effective immediately. The name change is part of the company's broader rebranding effort and directly reflects its growth initiatives to enhance its suite of service offerings and to introduce its growing array of services to customers in foreign markets, including Latin America and the Middle East. The change to the company's trading symbol is also intended to increase its profile within the investment community.

Aeon Global Health Announces Exclusive Marketing and Sales Agreement for Trusted Branded Pharmaceutical
Posted on Wednesday January 17, 2018

GAINESVILLE, Ga., Jan. 17, 2018 /PRNewswire/ -- Aeon Global Health, the operating arm of Authentidate Holding Corp. (ADAT), a growth-oriented provider of personalized, clinically actionable medical informatics and telemedicine, announced today that it has agreed with Sabal Therapeutics, LLC to be the primary laboratory marketer of Naprosyn®, the branded naproxen oral suspension USP. Under the agreement, Aeon will become the exclusive clinical laboratory marketing representative of Sabal and will market the drug alongside of its industry-leading drug monitoring service, thus providing physicians with an integrated, non-opiate solution for pain management.

Aeon Global Health Names Armando Moncada, MD, FCAP as Chief Medical Officer of its Anatomic Pathology Business
Posted on Wednesday January 10, 2018

GAINESVILLE, Ga., Jan. 10, 2018 /PRNewswire/ -- Aeon Global Health (ADAT), a growth-oriented provider of personalized, clinically actionable medical informatics and telemedicine, announced today that Armando Moncada, MD, FCAP, has been appointed to the position of Chief Medical Officer of its Anatomic Pathology business line. Dr. Moncada has more than 20 years' experience in the pathology field, the last ten of which he served as Chief Medical Officer of PCG Molecular.

Aeon Global Health Announces Key Texas Payer Agreement
Posted on Tuesday December 26, 2017

GAINESVILLE, Ga., Dec. 26, 2017 /PRNewswire/ -- Authentidate Holding Corp. (ADAT), a growth oriented company focused on developing and providing clinically actionable medical information and telemedicine services, announced today that Aeon Global Health's clinical laboratory has been selected to become a provider to the Texas Medicaid System. Covering nearly 4.8 million Texans, Texas Medicaid is responsible for insuring 16% of all of the states residents' according to the latest figures available. "We are pleased with this key development as we continue to execute on our strategy to increase our payer network," said Sonny Roshan, Chairman and CEO of Authentidate. "Receiving this important credentialing may allow us to increase our marketing focus in this highly populated state and position Aeon for even further growth in the Southwestern US.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.